Award details

Industrial biocatalysts by design: rational re-engineering of flavocytochrome p450 BM3 for chiral chemical synthesis

ReferenceE20186
Principal Investigator / Supervisor Professor Gordon Roberts
Co-Investigators /
Co-Supervisors
Professor Paul Cullis, Professor Andrew Munro, Dr Andrew Westlake
Institution University of Leicester
DepartmentBiochemistry
Funding typeResearch
Value (£) 243,929
StatusCompleted
TypeResearch Grant
Start date 01/01/2004
End date 31/12/2006
Duration36 months

Abstract

We will use rational and localised random mutagenesis of the mono-oxygenase P450 BM3 to generate catalysts that hydroxylate/epoxidate key molecules, providing chiral intermediates for complex organic synthesis. Our previous work shows the feasibility of re-designing BM3 to alter its substrate specificity and the regio- and stereoselectivity of oxidation. Molecular biology, enzymology and structural biology will be combined to engineer biotechnologically-exploitable variants. Specific targets to be addressed include 6,8-dihydoxyoctanoate (lipoate synthesis); indan-1,2-diol (protease inhibitors), 3,4-epoxybutanoate (carnitine synthesis) and styrene epoxides for synthesis of, e.g., beta-adrenergic agonists.

Summary

unavailable
Committee Closed Committee - Engineering & Biological Systems (EBS)
Research TopicsX – not assigned to a current Research Topic
Research PriorityX – Research Priority information not available
Research Initiative X - not in an Initiative
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file